Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ADAM19 |
| Upstream (Parents) |
|---|
| (<<) ABCF1 → ADAM19 |
| (<<) ATF2 → ADAM19 |
| (<<) CCNL1 → ADAM19 |
| (<<) CDK5 → ADAM19 |
| (<<) CNIH4 → ADAM19 |
| (<<) GNAQ → ADAM19 |
| (<<) GNAS → ADAM19 |
| (<<) LPXN → ADAM19 |
| (<<) LYPLA2 → ADAM19 |
| (<<) MAP2K3 → ADAM19 |
| (<<) NXT1 → ADAM19 |
| (<<) PIK3C3 → ADAM19 |
| (<<) PLCG2 → ADAM19 |
| (<<) PRKCQ → ADAM19 |
| (<<) RAD51L3 → ADAM19 |
| (<<) SMAD5 → ADAM19 |
| (<<) STAT4 → ADAM19 |
| Downstream (Children) |
|---|
| ADAM19 → AXL (>>) |
| ADAM19 → BDH1 (>>) |
| ADAM19 → CD4 (>>) |
| ADAM19 → CHST11 (>>) |
| ADAM19 → CSF2 (>>) |
| ADAM19 → ERBB3 (>>) |
| ADAM19 → FUT4 (>>) |
| ADAM19 → GNA15 (>>) |
| ADAM19 → GNAI2 (>>) |
| ADAM19 → GNB1L (>>) |
| ADAM19 → GNRH2 (>>) |
| ADAM19 → GSTZ1 (>>) |
| ADAM19 → HCN2 (>>) |
| ADAM19 → HSD11B1 (>>) |
| ADAM19 → IL1B (>>) |
| ADAM19 → IL1F7 (>>) |
| ADAM19 → ILKAP (>>) |
| ADAM19 → JAG1 (>>) |
| ADAM19 → KCNJ5 (>>) |
| ADAM19 → KLF11 (>>) |
| ADAM19 → KRT6B (>>) |
| ADAM19 → LIMK2 (>>) |
| ADAM19 → MAL (>>) |
| ADAM19 → MAN2A2 (>>) |
| ADAM19 → MMP25 (>>) |
| ADAM19 → MMP9 (>>) |
| ADAM19 → MSN (>>) |
| ADAM19 → MYH14 (>>) |
| ADAM19 → NFIB (>>) |
| ADAM19 → NFKBIE (>>) |
| ADAM19 → NOS3 (>>) |
| ADAM19 → PLCD1 (>>) |
| ADAM19 → PTK2B (>>) |
| ADAM19 → RNF5 (>>) |
| ADAM19 → RPS6KA3 (>>) |
| ADAM19 → SAA4 (>>) |
| ADAM19 → SH3TC1 (>>) |
| ADAM19 → TAF9 (>>) |
| ADAM19 → UBE2D4 (>>) |
| ADAM19 → UST (>>) |
| ADAM19 → VEGFC (>>) |
| ADAM19 → ZFP36L1 (>>) |
